vimarsana.com
Home
Live Updates
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) : comparemela.com
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
PALO ALTO, Calif., April 10, 2024 -- BridgeBio Pharma, Inc. , a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, today announced that on April 5, 2024, the...
Related Keywords
Vikram Bali ,
Linkedin ,
Bio Pharma Inc ,
Twitter ,
Nasdaq ,
Bridgebio Pharma Inc ,
Bio Pharma ,
Equity Plan ,
Nasdaq Listing Rule ,
Bridgebio Pharma ,
Bio Contact ,
Markets ,
comparemela.com © 2020. All Rights Reserved.